School of Basic Medical Sciences, Wuhan University, Wuhan, China.
Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China.
Cancer Sci. 2019 May;110(5):1633-1643. doi: 10.1111/cas.14004. Epub 2019 Apr 11.
Hepatocellular carcinoma (HCC) is a common cancer with poor prognosis. Hepatitis B virus (HBV) is one of the leading causes of HCC, but the precise mechanisms by which this infection promotes cancer development are not fully understood. Recently, miR-340-5p, a microRNA (miRNA) that has been identified as a cancer suppressor gene, was found to inhibit the migration and invasion of liver cancer cells. However, the effect of miR-340-5p on cell proliferation and apoptosis in HBV-associated HCC remains unknown. In our study, we show that miR-340-5p plays an important role during HBV infection and hepatocellular carcinoma development. Specifically, this miRNA directly binds to the mRNA encoding activating transcription factor 7 (ATF7), a protein that both promotes cell proliferation and suppresses apoptosis through its interaction with heat shock protein A member 1B (HSPA1B). We further found that miR-340-5p is downregulated by HBV, which enhances ATF7 expression, leading to enhanced cell proliferation and inhibition of apoptosis. Notably, ATF7 is upregulated in HCC tissue, suggesting that HBV may target miR-340-5p in vivo to promote ATF7/HSPA1B-mediated proliferation and apoptosis and regulate liver cancer progression. This work helps to elucidate the complex interactions between HBV and host miRNAs and further suggests that miR-340-5p may represent a promising candidate for the development of improved therapeutic strategies for HCC.
肝细胞癌 (HCC) 是一种预后较差的常见癌症。乙型肝炎病毒 (HBV) 是 HCC 的主要病因之一,但这种感染促进癌症发展的确切机制尚未完全了解。最近,miR-340-5p 被鉴定为一种抑癌基因的 microRNA (miRNA),被发现抑制肝癌细胞的迁移和侵袭。然而,miR-340-5p 对 HBV 相关 HCC 细胞增殖和凋亡的影响尚不清楚。在我们的研究中,我们表明 miR-340-5p 在 HBV 感染和肝细胞癌发展中发挥重要作用。具体来说,这种 miRNA 直接结合编码激活转录因子 7 (ATF7) 的 mRNA,ATF7 蛋白通过与热休克蛋白 A 成员 1B (HSPA1B) 相互作用,促进细胞增殖并抑制细胞凋亡。我们进一步发现 HBV 下调 miR-340-5p,从而增强 ATF7 的表达,导致细胞增殖增强和凋亡抑制。值得注意的是,ATF7 在 HCC 组织中上调,表明 HBV 可能在体内靶向 miR-340-5p 以促进 ATF7/HSPA1B 介导的增殖和凋亡,并调节肝癌进展。这项工作有助于阐明 HBV 与宿主 miRNAs 之间的复杂相互作用,并进一步表明 miR-340-5p 可能代表开发 HCC 更有效治疗策略的有前途的候选物。